A medical device can be brilliant and still die in a badly managed document trail. Greenlight Guru built a business around preventing that expensive, deeply unglamorous failure - then expanded from quality records into product development, clinical evidence and AI-assisted work.
Medical-device teams were losing release cycles to copy-paste compliance. Ketryx slipped into Jira and GitHub, automated the evidence trail, and built a $55 million-funded business around making regulated software less painful.
Sware is a Boston-based software company that modernizes GxP validation for life sciences. Its cloud-native Res_Q platform and developer-focused GxPNext product use AI and a decade of regulated validation knowledge to automate the computer system validation (CSV) work that the FDA and other regulators require - helping pharmaceutical, biotech, medical device and CDMO teams cut validation time and cost while staying audit-ready. Formerly Boston Technology Research (BTR), the company rebranded to Sware in 2022 and has raised roughly $26-27M to date.